title: Complete remission achieved by steroid pulse therapy following rituximab treatment in a case with autoimmune haemorrhaphilia due to anti-factor XIII antibodies.
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Ogawa
authors.forename: Masahiro
authors.initials: M
authors.lastname: Mihara
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Souri
authors.forename: Kunio
authors.initials: K
authors.lastname: Yanagisawa
authors.forename: Toshimasa
authors.initials: T
authors.lastname: Hayashi
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Kobayashi
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Shimizu
authors.forename: Hirono
authors.initials: H
authors.lastname: Iriuchishima
authors.forename: Takuma
authors.initials: T
authors.lastname: Ishizaki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Handa
authors.forename: Tukasa
authors.initials: T
authors.lastname: Osaki
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Nojima
authors.affiliation: Akitada Ichinose, MD, PhD, Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, 990-2331, Japan, Tel.: +81 23 628 5276, Fax: +81 23 628 5280, E-mail: aichinos@med.id.yamagata-u.ac.jp.
authors.forename: Akitada
authors.initials: A
authors.lastname: Ichinose
mesh_terms: D000368:Aged; D000906:Antibodies / Q000737:chemistry; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D057134:Antibodies, Neutralizing / Q000737:chemistry; D015897:Comorbidity; D005176:Factor XIII / Q000737:chemistry / Q000276:immunology*; D006467:Hemophilia A / Q000188:drug therapy*; D006470:Hemorrhage; D006801:Humans; D007166:Immunosuppressive Agents / Q000737:chemistry; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D000069283:Rituximab; D013256:Steroids / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D058846:Antibodies, Monoclonal, Murine-Derived; D057134:Antibodies, Neutralizing; D007166:Immunosuppressive Agents; D013256:Steroids; D000069283:Rituximab; D005176:Factor XIII; D011241:Prednisone